+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceutical Contract Manufacturing Market to 2027 - Global Analysis and Forecasts by Product; Service, and Geography

  • ID: 5014172
  • Report
  • March 2020
  • Region: Global
  • 174 pages
  • The Insight Partners
UP TO OFF
until Sep 30th 2021

FEATURED COMPANIES

  • AbbVie Inc.
  • Ajinomoto Co., Inc
  • General Electric
  • Lonza Group AG
  • Merck KGaA
  • Samsung Biologics
The biopharmaceuticals contract manufacturing market was valued at US$ 13,727.13 million in 2019 and is expected to grow at a CAGR of 8.2% from 2020 to 2027 to reach US$ 25,497.26 million by 2027.

Driving factors of the biopharmaceuticals contract manufacturing market are increasing trend of outsourcing among pharmaceuticals companies and elevating demand for biologics. However, growing competition in biopharmaceutical contract manufacturing industry is hindering the growth of the market.

The contract manufacturing organization (CMO) offers numerous benefits, including reducing investments in facilities and drug development costs, to pharmaceutical companies, thereby improving net cash flow. Outsourcing is cheaper and increases the efficiency of manufacturing processes. Also, it allows pharmaceutical and biotechnology companies to redirect resources to other areas. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to pharmaceutical companies. Presently, many pharmaceuticals and biotechnology companies outsource various services from early-stage drug development to commercial-scale manufacturing. As the pharmaceuticals industry is shifting from large-scale production to more niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is leading to the rise in inclination toward CMOs.

The global biopharmaceuticals contract manufacturing market is segmented into product and services. The biopharmaceuticals contract manufacturing market, by product, is segmented into biologics and biosimilars. The biologics segment held the largest share of the market in 2019, whereas the biosimilar segment is anticipated to register the highest CAGR in the market during the forecast period. Based on services, the market is segmented into development process, final dosage operations, and final packaging. The development process held the largest share of the market in 2019, whereas analytical and quality control segment is estimated to register the highest CAGR in the market during the forecast period.

Some of the essential primary and secondary sources included in the report are The Pharma & Biopharma Outsourcing Association (PBOA), Centers for Disease Control and Prevention, and Organization for Economic Co-operation and Development.

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biopharmaceuticals contract manufacturing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceuticals contract manufacturing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Ajinomoto Co., Inc
  • General Electric
  • Lonza Group AG
  • Merck KGaA
  • Samsung Biologics
1. Introduction
1.1 Study Scope
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Biopharmaceutical Contract Manufacturing Market - By Product
1.3.2 Global Biopharmaceutical Contract Manufacturing Market - By Service
1.3.3 Global Biopharmaceutical Contract Manufacturing Market - By Geography

2. Biopharmaceutical Contract Manufacturing Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Biopharmaceutical Contract Manufacturing - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinion

5. Biopharmaceuticals Contract Manufacturing Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increasing Outsourcing by Pharmaceutical Companies
5.1.2 Increasing Demand of Biologics
5.2 Key Market Restraints
5.2.1 Increasing Competition in the Industry
5.3 Key Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Consolidation in Pharmaceutical CMO Industry
5.5 Impact Analysis

6. Biopharmaceutical Contract Manufacturing Market - Global Analysis
6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast And Analysis
6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
6.3.1 Lonza Group AG
6.3.2 Thermo Fisher Scientific, Inc.

7. Biopharmaceuticals Contract Manufacturing Market Analysis - By Product
7.1 Overview
7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2019 and 2027)
7.3 Biologics
7.3.1 Overview
7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Monoclonal Antibodies
7.3.3.1 Overview
7.3.3.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
7.3.4 Recombinant Proteins
7.3.4.1 Overview
7.3.4.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Vaccines
7.3.5.1 Overview
7.3.5.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.7 Others: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Biosimilars
7.4.1 Overview
7.4.2 Biosimilars: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)

8. Biopharmaceuticals Contract Manufacturing Market - By Service
8.1 Overview
8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2019 and 2027 (%)
8.3 Development Process
8.3.1 Overview
8.3.2 Development Process: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Final Dosage Operation
8.4.1 Overview
8.4.2 Final Dosage Operation: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Analytical and Quality Control
8.5.1 Overview
8.5.2 Analytical and Quality Control: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Final Packaging
8.6.1 Overview
8.6.2 Final Packaging: Biopharmaceuticals Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)

9. Biopharmaceutical Contract Manufacturing Market - Geographic Analysis
9.1 North America: Biopharmaceutical Contract Manufacturing Market
9.1.1 Overview
9.1.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.1.3.1 North America: Biologics Market, by Type, 2018-2027 (USD Million)
9.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
9.1.6 US: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.1.6.2.1 US: Biologics Market, by Type, 2018-2027 (USD Million)
9.1.6.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.1.7 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.1.7.2.1 Canada: Biologics Market, by Type, 2018-2027 (USD Million)
9.1.7.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.1.8 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.1.8.2.1 Mexico: Biologics Market, by Type, 2018-2027 (USD Million)
9.1.8.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.2 Europe: Biopharmaceutical Contract Manufacturing Market
9.2.1 Overview
9.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.2.3.1 Europe: Biologics Market, by Type, 2018-2027 (USD Million)
9.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.2.6.2.1 Germany: Biologics Market, by Type, 2018-2027 (USD Million)
9.2.7 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.2.8 UK: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 UK: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.2.8.2.1 UK: Biologics Market, by Type, 2018-2027 (USD Million)
9.2.8.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.2.9 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.2.9.2.1 France: Biologics Market, by Type, 2018-2027 (USD Million)
9.2.9.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.2.10 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.2.10.2.1 Spain: Biologics Market, by Type, 2018-2027 (USD Million)
9.2.10.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.2.11 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.2.11.2.1 Italy: Biologics Market, by Type, 2018-2027 (USD Million)
9.2.11.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market
9.3.1 Overview
9.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.3.3.1 Asia Pacific: Biologics Market, by Type, 2018-2027 (USD Million)
9.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
9.3.6 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.3.6.2.1 China: Biologics Market, by Type, 2018-2027 (USD Million)
9.3.6.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.3.7 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.3.7.2.1 Japan: Biologics Market, by Type, 2018-2027 (USD Million)
9.3.7.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.3.8 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.3.8.2.1 India: Biologics Market, by Type, 2018-2027 (USD Million)
9.3.8.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.3.9 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.3.9.2.1 South Korea: Biologics Market, by Type, 2018-2027 (USD Million)
9.3.9.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.3.10 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.3.10.2.1 Australia: Biologics Market, by Type, 2018-2027 (USD Million)
9.3.10.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market
9.4.1 Overview
9.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.4.3.1 Middle East & Africa: Biologics Market, by Type, 2018-2027 (USD Million)
9.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country - 2019 & 2027, (%)
9.4.6 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.4.6.2.1 Saudi Arabia: Biologics Market, by Type, 2018-2027 (USD Million)
9.4.6.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.4.7 UAE: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.4.7.2.1 UAE: Biologics Market, by Type, 2018-2027 (USD Million)
9.4.7.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.4.8 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
9.4.8.1 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.4.8.2.1 South Africa: Biologics Market, by Type, 2018-2027 (USD Million)
9.4.8.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.5 South and Central America: Biopharmaceutical Contract Manufacturing Market
9.5.1 Overview
9.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.5.3.1 South and Central America: Biologics Market, by Type, 2018-2027 (USD Million)
9.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.5.6.2.1 Brazil: Biologics Market, by Type, 2018-2027 (USD Million)
9.5.6.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)
9.5.7 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2018-2027 (USD Million)
9.5.7.2.1 Argentina: Biologics Market, by Type, 2018-2027 (USD Million)
9.5.7.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2018-2027 (USD Million)

10. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market
10.1 North America: Impact assessment of COVID-19 Pandemic
10.2 Europe: Impact assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
10.4 Rest of World: Impact Assessment of COVID-19 Pandemic

11. Biopharmaceutical Contract Manufacturing Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.2 THERMO FISHER SCIENTIFIC INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 General Electric Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 MERCK KGAA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Lonza
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Samsung Biologics.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AbbVie Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 WUXI BIOLOGICS
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Ajinomoto Co. Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Inno Bio Ventures Sdn Bhd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Lonza Group AG
  • Boehringer Ingelheim International GmbH.
  • Inno Biologics Ventures Sdn Bhd
  • Thermo Fisher Scientific
  • AbbVie Inc.
  • WuXi Biologics
  • General Electric
  • Samsung Biologics
  • Merck KGaA
  • Ajinomoto Co., Inc
Note: Product cover images may vary from those shown
Adroll
adroll